Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 13Head & Neck 3Dermatologic 3Tumor-Agnostic 2Thoracic 2Other hematologic neoplasm 2Gastrointestinal 2Other solid neoplasm 1Lymphoid 1CNS 1

Conditions

Weight Loss 1Lung Neoplasms 1Gastrointestinal Neoplasms 1Cachexia 1Barrett Esophagus 1Anorexia 1

Interventions

Oxaliplatin 1439Fluorouracil 1319Capecitabine 1114Gemcitabine 1057Leucovorin 939Bevacizumab 847Irinotecan 830Cisplatin 676Radiotherapy 560Cetuximab 482pembrolizumab 435Paclitaxel 401Drug Therapy 358Nivolumab 350130-nm albumin-bound paclitaxel 329Docetaxel 290Sorafenib 288S 1 (combination) 279Folfox protocol 266Albumin-Bound Paclitaxel 263Surgical Procedures, Operative 258lenvatinib 222sintilimab 218tislelizumab 214durvalumab 212regorafenib 209Magnetic Resonance Spectroscopy 205apatinib 204Radiosurgery 204Neoadjuvant Therapy 190

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Melatonin × Gastrointestinal × Clear all
NCT01566474 2019-09-13

Melatonin Associated to Acid Inhibition for Chemoprevention in Barret Esophagus: a Pilot Study

Aragon Institute of Health Sciences

Phase 3 Completed
80 enrolled
Gastrointestinal

Barrett Esophagus

NCT00513357 2012-12-11

Melatonin Versus Placebo and the Effect on Appetite in Advanced Cancer Patients

M.D. Anderson Cancer Center

Phase 3 Completed
82 enrolled 7 charts
GastrointestinalThoracic

Anorexia, Cachexia, Gastrointestinal Neoplasms, Lung Neoplasms, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡